167 related articles for article (PubMed ID: 37770455)
1. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
medRxiv; 2020 Oct; ():. PubMed ID: 33140066
[TBL] [Abstract][Full Text] [Related]
5. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
[TBL] [Abstract][Full Text] [Related]
8. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
11. The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study.
Meireles P; Costa JP; Novais MJ; Miranda D; Lopes MM; Severo M; Barros H
Int J Public Health; 2022; 67():1604548. PubMed ID: 36339661
[No Abstract] [Full Text] [Related]
12. Risk of infection and contribution to transmission of SARS-CoV-2 in school staff: a systematic review.
Karki SJ; Joachim A; Heinsohn T; Lange B
BMJ Open; 2021 Nov; 11(11):e052690. PubMed ID: 34732489
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
[TBL] [Abstract][Full Text] [Related]
14. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.
Goldfarb DM; Mâsse LC; Watts AW; Hutchison SM; Muttucomaroe L; Bosman ES; Barakauskas VE; Choi A; Dhillon N; Irvine MA; Reicherz F; O'Reilly C; Sediqi S; Xu RY; Razzaghian HR; Sadarangani M; Coombs D; O'Brien SF; Lavoie PM
BMJ Open; 2022 Apr; 12(4):e057846. PubMed ID: 35383082
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
19. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
Javed W; Abidi SHB; Baqar JB
BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
